Molecular role of PIEZO1 in endochondral ossification

骨骼发育、生长和重塑是高度复杂的过程，涉及许多具有独特功能的不同细胞类型。大部分轴骨和无骨骨骼通过软骨内骨化发育，这是一个依赖于软骨细胞的过程，软骨细胞产生软骨中间体，随后被骨取代。我们以前已经确定了机械激活离子通道PIEZO 1在骨骼重塑和软骨内骨化中的关键作用。而PIEZO 1的第一个功能取决于其在骨包埋的骨细胞中的表达，其在软骨内骨化中的作用由生长板软骨细胞中的PIEZO 1表达介导。更具体地说，我们对不同骨骼细胞类型中PIEZO 1缺乏的条件性小鼠模型的集体分析表明，软骨细胞特异性PIEZO 1失活强烈损害出生后小梁骨形成。此外，用培养的骨细胞进行的分子实验表明，PIEZO 1特异性地控制软骨细胞到成骨细胞的转分化过程。 该项目的主要目标是充分揭示PIEZO 1在软骨细胞中的分子作用，同时利用其他小鼠模型，允许诱导PIEZO 1失活和谱系追踪。我们还将联合收割机结合软骨细胞特异性PIEZO 1失活与其他遗传修饰，以指定潜在的下游介质的作用。由于软骨内骨化过程在骨折愈合过程中也会重现，我们希望利用我们现有的专业知识在受控截骨模型中分析这一过程。最后，将进行细胞培养实验以将体内发现与受损的机械感觉联系起来。我们的中心假设是PIEZO 1是促进出生后骨小梁形成和骨再生中软骨细胞向成骨细胞转分化所必需的。由于我们工作计划的许多方面依赖于已建立的方法，并且由于条件性PIEZO 1失活的小鼠的表型不仅独特，而且非常严重，因此我们期望获得许多关于PIEZO 1在软骨内骨化中的作用的新见解。我们的发现不仅从基础科学的角度来看是相关的，而且它们也将影响我们对软骨细胞相关疾病的理解。

Skeletal development, growth and remodeling are highly complex processes involving many different cell types with unique functions. The majority of the axial and appendicular skeleton develops by endochondral ossification, a process depending on chondrocytes, which produce a cartilage intermediate that is subsequently replaced by bone. We have previously identified a key role of the mechanically activated ion channel PIEZO1 in both, skeletal remodeling and endochondral ossification. Whereas the first function of PIEZO1 depends on its expression in bone-embedded osteocytes, its role in endochondral ossification is mediated by PIEZO1 expression in growth plate chondrocytes. More specifically, our collective analyses of conditional mouse models with PIEZO1 deficiency in different skeletal cell types has demonstrated that chondrocyte-specific PIEZO1 inactivation strongly impairs postnatal trabecular bone formation. Moreover, molecular experiments with cultured bone cells suggested that PIEZO1 specifically controls the chondrocyte-to-osteoblast transdifferentation process. The primary goal of this project is to fully uncover the molecular role of PIEZO1 in chondrocytes, also taking advantage of additional mouse models allowing inducible PIEZO1 inactivation and lineage tracing. We will also combine the chondrocyte-specific PIEZO1 inactivation with other genetic modifications to specify the role of potential downstream mediators. Since the process of endochondral ossification is also recapitulated during fracture healing, we want to take advantage of our existing expertise in analyzing this process in a controlled osteotomy model. Finally, cell culture experiments will be performed to link the in vivo findings to impaired mechanosensation. Our central hypothesis is that PIEZO1 is required to promote chondrocyte-to-osteoblast transdifferentation in postnatal trabecular bone formation and bone regeneration. Since many aspects of our working programme rely on established methodology, and since the phenotypes of mice with conditional PIEZO1 inactivation are not only unique, but also remarkably severe, we expect to gain many novel insights into the role of PIEZO1 in endochondral ossification. Our findings will not only be relevant from a basic science perspective, but they will also impact our understanding of chondrocyte-related disorders.